An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature

OMICS A Journal of Integrative Biology

Volumn 18, Issue 5, 2014, Pages 310-323

  Chiang, Jung Hsien ^a   Cheng, Wan Shu ^a   Hood, Leroy ^b   Tian, Qiang ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENETIC MARKER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EMBRYONIC STEM CELL; EPIGENETICS; FEMALE; FGFR2 GENE; GAP43 GENE; GENE; GENETIC LINKAGE; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; HUMAN CELL; MALE; MGMT GENE; NKX2 2 GENE; NTRK2 GENE; NTRK3 GENE; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHENOTYPE; POU3F2 GENE; PRIORITY JOURNAL; SOX2 GENE; TRANSCRIPTOMICS; UPREGULATION; AREA UNDER THE CURVE; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; KAPLAN MEIER METHOD; MORTALITY; PHYSIOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

AREA UNDER CURVE; BRAIN NEOPLASMS; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GLIOBLASTOMA; HUMANS; INDIVIDUALIZED MEDICINE; KAPLAN-MEIER ESTIMATE; NEOPLASTIC STEM CELLS; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84900013457     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0084     Document Type: Article

References (77)

1. Aigner L, Arber S, Kapfhammer JP, et al. (1995). Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83, 269-278.
2. Assou S, Le Carrour T, Tondeur S, et al. (2007). A meta-analysis of human embryonic stem cells Transcriptome integrated into a web-based expression atlas. Stem Cells 25, 961-973. (Pubitemid 46572593)
3. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, and Lovell-Badge R. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Devel 17, 126-140. (Pubitemid 36062514)
4. Bao S, Wu Q, Li Z, et al. (2008). Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68, 6043-6048.
5. Bao S, Wu Q, Mclendon RE, et al. (2006a). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760. (Pubitemid 44949604)
6. Bao S, Wu Q, Sathornsumetee S, et al. (2006b). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66, 7843-7848. (Pubitemid 44299144)
7. Baylin SB, and Ohm JE. (2006). Epigenetic gene silencing in cancer. A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6, 107-116. (Pubitemid 43361543)
8. Ben-Porath I, Thomson MW, Carey VJ, et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40, 499-507. (Pubitemid 351601215)
9. Benowitz LI, and Routtenberg A. (1997). GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20, 84-91. (Pubitemid 27050703)
10. Boyer LA, Lee TI, Cole MF, et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956. (Pubitemid 41345211)
11. Briscoe J, Sussel L, Serup P, et al. (1999). Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 398, 622-627. (Pubitemid 29183690)
12. Calabrese C, Poppleton H, Kocak M, et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82. (Pubitemid 46054518)
13. Chiang C, Litingtung Y, Lee E, et al. (1996). Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383, 407-413. (Pubitemid 26330823)
14. Dent EW, and Meiri KF. (1998). Distribution of phosphorylated GAP-43 (neuromodulin) in growth cones directly reflects growth cone behavior. J Neurobiol 35, 287-299. (Pubitemid 28246568)
15. Ericson J, Muhr J, Placzek M, Lints T, Jessel TM, and Edlund T. (1995). Sonic hedgehog induces the differentiation of ventral forebrain neurons: A common signal for ventral patterning within the neural tube. Cell 81, 747-756.
16. Ever L, Zhao R, Eswarakumar VP, and Gaiano N. (2008). Fibroblast growth factor receptor 2 plays an essential role in telencephalic progenitors. Develop Neurosci 30, 306-318.
17. Feinberg AP, Ohlsson R, and Henikoff S. (2006). The epigenetic progenitor origin of human cancer. Nat Rev Genet 7, 21-33. (Pubitemid 41828945)
18. Feinberg AP, and Tycko B (2004). The history of cancer epigenetics. Nat Rev Cancer 4, 143-153. (Pubitemid 38198742)
19. Feinberg AP, and Vogelstein B. (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92. (Pubitemid 13154475)
20. Fernandez PC, Frank SR, Wang L, et al. (2003). Genomic targets of the human c-Myc protein. Genes Devel 17, 1115-1129. (Pubitemid 36534986)
21. Figueroa ME, Skrabanek L, Li Y, et al. (2009). MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 114, 3448-3458.
22. Fuccillo M, Joyner AL, and Fishell G. (2006). Morphogen to mitogen: The multiple roles of hedgehog signalling in vertebrate neural development. Nat Rev Neurosci 7, 772-783. (Pubitemid 44435260)
23. Galli R, Binda E, Orfanelli U, et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64, 7011-7021. (Pubitemid 39331011)
24. Graham V, Khudyakov J, Ellis P, and Pevny L. (2003). SOX2 functions to maintain neural progenitor identity. Neuron 39, 749-765. (Pubitemid 37088088)
25. Gravendeel LaM, Kouwenhoven MCM, Gevaert O, et al. (2009). Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69, 9065-9072.
26. Gutin G, Fernandes M, Palazzolo L, et al. (2006). FGF signalling generates ventral telencephalic cells independently of SHH. Development 133, 2937-2946. (Pubitemid 44314271)
27. Hagino-Yamagishi K, Saijoh Y, Ikeda M, Ichikawa M, Minamikawa-Tachino R, and Hamada H. (1997). Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. Brain Res 752, 261-268. (Pubitemid 27155326)
28. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, and Rosenfeld MG. (1989). Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35-42. (Pubitemid 19172600)
29. Hegi ME, Diserens A-C, Gorlia T, et al. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. New Eng J Med 352, 997-1003. (Pubitemid 40349502)
30. Hemmati HD, Nakano I, Lazareff JA, et al. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci 100, 15178-15183. (Pubitemid 37518036)
31. Holliday R, and Pugh J. (1975). DNA modification mechanisms and gene activity during development. Science 187, 226-232.
32. Irizarry RA, Ladd-Acosta C, Wen B, et al. (2009). The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41, 178-186.
33. Klein R, Parada LF, Coulier F, and Barbacid M. (1989). trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J 8, 3701-3709. (Pubitemid 20016049)
34. Klein R, Conway D, Parada LF, and Barbacid M. (1990a). The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 61, 647-656.
35. Klein R, Martin-Zanca D, Barbacid M, and Parada LF. (1990b). Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. Development 109, 845-850.
36. Klein R, Silos-Santiago I, Smeyne RJ, et al. (1994). Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature 368, 249-251. (Pubitemid 24108842)
37. Klein R, Smeyne RJ, Wurst W, et al. (1993). Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75, 113-122. (Pubitemid 23306025)
38. Lamballe F, Klein R, and Barbacid M. (1991). trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66, 967-979. (Pubitemid 121001730)
39. Lee J, Kotliarova S, Kotliarov Y, et al. (2006a). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403. (Pubitemid 43668737)
40. Lee TI, Jenner RG, Boyer LA, et al. (2006b). Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125, 301-313. (Pubitemid 44313811)
41. Levi-Montalcini R. (1987). The nerve growth factor: Thirty-five years later. EMBO J 6, 1145-1154.
42. Li Z, Bao S, Wu Q, et al. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15, 501-513.
43. Li Z, Van Calcar S, Qu C, CaveneeWK, ZhangMQ, and Ren B. (2003). A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci 100, 8164-8169. (Pubitemid 36842516)
44. Maric D, Fiorio Pla A, Chang YH, and Barker JL. (2007). Selfrenewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors. J Neurosci 27, 1836-1852.
45. Marti E, Bumcrot DA, Takada R, and McMahon AP. (1995). Requirement of 19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. Nature 375, 322-325.
46. Mason I. (2007). Initiation to end point: The multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci 8, 583-596. (Pubitemid 47093932)
47. Metz CE. (1978). Basic principles of ROC analysis. Seminars Nuclear Med 8, 283-298. (Pubitemid 9075026)
48. Miyagi S, Masui S, Niwa H, Saito T, Shimazaki T, Okano H, et al. (2008). Consequence of the loss of Sox2 in the developing brain of the mouse. FEBS Lett 582, 2811-2815.
49. Murat A, Migliavacca E, Gorlia T, et al. (2008). Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26, 3015-3024.
50. Nakai S, Kawano H, Yudate T, et al. (1995). The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Devel 9, 3109-3121. (Pubitemid 26018144)
51. Noushmehr H, Weisenberger DJ, Diefes K, et al. (2010). Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522.
52. Ordway JM, Budiman MA, Korshunova Y, et al. (2007). Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS ONE 2, e1314.
53. Paek H, Gutin G, and Hébert JM. (2009). FGF signaling is strictly required to maintain early telencephalic precursor cell survival. Development 136, 2457-2465.
54. Parsons DW, Jones S, Zhang X, et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812.
55. Pevny L, and Rao MS. (2003). The stem-cell menagerie. Trends Neurosci 26, 351-359. (Pubitemid 36794551)
56. Phillips HS, Kharbanda S, Chen R, et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173. (Pubitemid 43357943)
57. Rauch TA, Zhong X, Wu X, et al. (2008). High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci 105, 252-257.
58. Riggs AD. (1975). X inactivation, differentiation, and DNA methylation. Cytogen Genome Res 14, 9-25.
59. Roelink H, Porter JA, Chiang C, et al. (1995). Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81, 445-455.
60. Schonemann MD, Ryan AK, McEvilly RJ, et al. (1995). Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Devel 9, 3122-3135. (Pubitemid 26018145)
61. Singh SK, Hawkins C, Clarke ID, et al. (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401. (Pubitemid 39551674)
62. Sperger JM, Chen X, Draper JS, et al. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci 100, 13350-13355. (Pubitemid 37444745)
63. Strittmatter SM, Valenzuela D, Kennedy TE, Neer EJ, and Fishman MC. (1990). G0 is a major growth cone protein subject to regulation by GAP-43. Nature 344, 836-841.
64. Sugitani Y, Nakai S, Minowa O, et al. (2002). Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. Genes Devel 16, 1760-1765. (Pubitemid 34803892)
65. Takahashi K, Tanabe K, Ohnuki M, et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (Pubitemid 350138099)
66. Takahashi K, and Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
67. The Cancer Genome Atlas Research Network. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
68. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, and Issa J-PJ. (1999). CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci 96, 8681-8686. (Pubitemid 29354851)
69. Uchikawa M, Ishida Y, Takemoto T, Kamachi Y, and Kondoh H. (2003). Functional analysis of chicken Sox2 enhancers highlights an array of diverse regulatory elements that are conserved in mammals. Devel Cell 4, 509-519. (Pubitemid 36437558)
70. Umemori H, Linhoff MW, Ornitz DM, and Sanes JR. (2004). FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 118, 257-270. (Pubitemid 38962580)
71. Verhaak RGW, Hoadley KA, Purdom E, et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110.
72. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, and Wernig M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041.
73. Vokes SA, Ji H, Mccuine S, et al. (2007). Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development 134, 1977-1989. (Pubitemid 46939242)
74. Xu Q, Guo L, Moore H, Waclaw RR, Campbell K, and Anderson SA. (2010). Sonic Hedgehog signaling confers ventral telencephalic progenitors with distinct cortical interneuron fates. Neuron 65, 328-340.
75. Xu Q, Wonders CP, and Anderson SA. (2005). Sonic hedgehog maintains the identity of cortical interneuron progenitors in the ventral telencephalon. Development 132, 4987-4998. (Pubitemid 41764010)
76. Zappone MV, Galli R, Catena R, et al. (2000). Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development 127, 2367-2382. (Pubitemid 30386576)
77. Zweig MH, and Campbell G. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39, 561-577. (Pubitemid 23118304)